Relmada Therapeutics (RLMD) Gains from Investment Securities (2014 - 2026)
Relmada Therapeutics (RLMD) reported Gains from Investment Securities of $125.0 for Q1 2026, down 100.0% year-over-year from $11.3 million in Q1 2025, and up 100.12% on a QoQ basis from -$107924.0 in Q4 2025.
Relmada Therapeutics (RLMD) has 11 years of Gains from Investment Securities data on file, last reported at $125.0 in Q1 2026.
- Quarterly Gains from Investment Securities fell 100.0% year-over-year to $125.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $125.0 (down 100.0% YoY) and the FY2025 annual result came in at $5.4 million, up 4840.11% from the prior year.
- Gains from Investment Securities advanced to $125.0 in Q1 2026 per RLMD's latest filing, from -$107924.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $13.1 million in Q3 2024 and bottomed at -$3.3 million in Q4 2023.
- The 5-year median for Gains from Investment Securities is $47203.0 (2025), against an average of $1.5 million.
- The widest annual swing landed in 2023, when Gains from Investment Securities plunged 9932.59%; it then surged 7765.9% in 2024.
- Tracing RLMD's Gains from Investment Securities over 5 years: stood at -$33351.0 in 2022, then sank by 9932.59% to -$3.3 million in 2023, then surged by 101.22% to $40844.0 in 2024, then plunged by 364.23% to -$107924.0 in 2025, then jumped by 100.12% to $125.0 in 2026.
- Per Business Quant, the three latest RLMD Gains from Investment Securities figures stand at $125.0 (Q1 2026), -$107924.0 (Q4 2025), and -$81438.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Relmada Therapeutics | 595.35 Mn | 595.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 125.00 |
| Mar 31, 2026 | 125.00 |
| Dec 31, 2025 | -107,924.00 |
| Dec 31, 2025 | -107,924.00 |
| Sep 30, 2025 | -81,438.00 |
| Sep 30, 2025 | -81,438.00 |
| Jun 30, 2025 | 47,203.00 |
| Jun 30, 2025 | 47,203.00 |
| Mar 31, 2025 | 11.26 Mn |
| Mar 31, 2025 | 11.26 Mn |
| Dec 31, 2024 | 40,844.00 |
| Dec 31, 2024 | 40,844.00 |
| Sep 30, 2024 | 13.05 Mn |
| Sep 30, 2024 | 13.05 Mn |
| Jun 30, 2024 | 133,114.00 |
| Jun 30, 2024 | 133,114.00 |
| Mar 31, 2024 | 3.96 Mn |
| Mar 31, 2024 | 3.96 Mn |
| Dec 31, 2023 | -3.35 Mn |
| Dec 31, 2023 | -3.35 Mn |
| Sep 30, 2023 | 165,939.00 |
| Sep 30, 2023 | 165,939.00 |
| Jun 30, 2023 | 160,939.00 |
| Jun 30, 2023 | 160,939.00 |
| Mar 31, 2023 | -666,708.00 |
| Mar 31, 2023 | -666,708.00 |
| Dec 31, 2022 | -33,351.00 |
| Dec 31, 2022 | -33,351.00 |
| Sep 30, 2022 | 745,000.00 |
| Sep 30, 2022 | 745,000.00 |
| Jun 30, 2022 | 17,886.00 |
| Jun 30, 2022 | 17,886.00 |
| Mar 31, 2022 | 223,438.00 |
| Mar 31, 2022 | 223,438.00 |
| Dec 31, 2021 | 457,500.00 |
| Dec 31, 2021 | 457,500.00 |
| Sep 30, 2021 | 1.52 Mn |
| Sep 30, 2021 | 1.52 Mn |
| Jun 30, 2021 | -123,590.00 |
| Jun 30, 2021 | -123,590.00 |
| Mar 31, 2021 | 1.52 Mn |
| Mar 31, 2021 | 1.52 Mn |
| Dec 31, 2020 | 455,938.00 |
| Dec 31, 2020 | 455,938.00 |
| Sep 30, 2020 | 215,312.00 |
| Sep 30, 2020 | 215,312.00 |
| Jun 30, 2020 | 12,810.00 |
| Jun 30, 2020 | 12,810.00 |
| Mar 31, 2020 | 600,000.00 |
| Mar 31, 2020 | 600,000.00 |
| Dec 31, 2019 | -4.68 Mn |
| Dec 31, 2019 | -4.68 Mn |
| Sep 30, 2019 | 900,000.00 |
| Sep 30, 2019 | 900,000.00 |
| Jun 30, 2019 | 712,500.00 |
| Jun 30, 2019 | 712,500.00 |
| Mar 31, 2019 | 25,625.00 |
| Mar 31, 2019 | 25,625.00 |
| Dec 31, 2018 | 25,625.00 |
| Dec 31, 2018 | 25,625.00 |
| Sep 30, 2018 | 25,625.00 |
| Sep 30, 2018 | 25,625.00 |
| Jun 30, 2018 | 2.65 Mn |
| Jun 30, 2018 | 2.65 Mn |
| Mar 31, 2018 | 5,000.00 |
| Mar 31, 2018 | 5,000.00 |
| Dec 31, 2017 | 37,625.00 |
| Dec 31, 2017 | 37,625.00 |
| Jun 30, 2017 | 7,000.00 |
| Jun 30, 2017 | 7,000.00 |
| Dec 31, 2014 | 5.15 Mn |
| Dec 31, 2014 | 5.15 Mn |
| Sep 30, 2014 | 4.88 Mn |
| Sep 30, 2014 | 4.88 Mn |